Meihong Lin

3.7k total citations · 2 hit papers
21 papers, 3.1k citations indexed

About

Meihong Lin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Meihong Lin has authored 21 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Meihong Lin's work include Drug Transport and Resistance Mechanisms (4 papers), Adipose Tissue and Metabolism (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Meihong Lin is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Adipose Tissue and Metabolism (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Meihong Lin collaborates with scholars based in United States, Netherlands and Germany. Meihong Lin's co-authors include Howard Y. Chang, Adam S. Adler, Tiara L.A. Kawahara, Parveen Abidi, Jingwen Liu, Ron McCord, Elisabeth Berber, Katrin F. Chua, Eriko Michishita and Lisa D. Boxer and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Circulation.

In The Last Decade

Meihong Lin

21 papers receiving 3.0k citations

Hit Papers

Berberine is a novel cholesterol-lowering drug working th... 2004 2026 2011 2018 2004 2009 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meihong Lin United States 17 1.5k 861 592 547 388 21 3.1k
Shuyi Si China 29 1.9k 1.2× 1.3k 1.5× 477 0.8× 68 0.1× 301 0.8× 86 3.5k
Gopalakrishnan Ramakrishnan United States 29 1.5k 1.0× 187 0.2× 385 0.7× 120 0.2× 285 0.7× 64 2.9k
Luciana Tessitore Italy 29 1.5k 1.0× 184 0.2× 550 0.9× 320 0.6× 810 2.1× 103 3.3k
Anjana Bhardwaj United States 17 1.4k 0.9× 186 0.2× 440 0.7× 700 1.3× 195 0.5× 37 2.6k
Gu Kong South Korea 41 2.7k 1.7× 176 0.2× 932 1.6× 171 0.3× 274 0.7× 101 4.2k
Michihiro Mutoh Japan 33 2.2k 1.4× 937 1.1× 954 1.6× 55 0.1× 405 1.0× 168 4.8k
Dong Xiao China 34 2.8k 1.8× 400 0.5× 660 1.1× 71 0.1× 341 0.9× 88 3.8k
Kodappully Sivaraman Siveen United States 38 2.7k 1.8× 432 0.5× 951 1.6× 71 0.1× 263 0.7× 74 4.7k
Ming‐Ju Hsieh Taiwan 32 1.9k 1.2× 297 0.3× 689 1.2× 73 0.1× 298 0.8× 140 3.0k
Shu‐Huei Tsai Taiwan 19 822 0.5× 252 0.3× 192 0.3× 220 0.4× 202 0.5× 28 1.7k

Countries citing papers authored by Meihong Lin

Since Specialization
Citations

This map shows the geographic impact of Meihong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meihong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meihong Lin more than expected).

Fields of papers citing papers by Meihong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meihong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meihong Lin. The network helps show where Meihong Lin may publish in the future.

Co-authorship network of co-authors of Meihong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Meihong Lin. A scholar is included among the top collaborators of Meihong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meihong Lin. Meihong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bleasby, Kelly, Robert Houle, Michael J. Hafey, et al.. (2021). Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters. Viruses. 13(8). 1566–1566. 17 indexed citations
3.
Chan, Grace, Robert Houle, Meihong Lin, et al.. (2019). Role of transporters in the disposition of a novel β-lactamase inhibitor: relebactam (MK-7655). Journal of Antimicrobial Chemotherapy. 74(7). 1894–1903. 13 indexed citations
4.
Bleasby, Kelly, Kerry L. Fillgrove, Robert Houle, et al.. (2019). In Vitro Evaluation of the Drug Interaction Potential of Doravirine. Antimicrobial Agents and Chemotherapy. 63(4). 23 indexed citations
5.
Li, Lingjie, Orly L. Wapinski, Miao-Chih Tsai, et al.. (2013). Targeted Disruption of Hotair Leads to Homeotic Transformation and Gene Derepression. Cell Reports. 5(1). 3–12. 265 indexed citations
6.
Chang, Anne Lynn S., Patrick Bitter, Kun Qu, et al.. (2012). Rejuvenation of Gene Expression Pattern of Aged Human Skin by Broadband Light Treatment: A Pilot Study. Journal of Investigative Dermatology. 133(2). 394–402. 32 indexed citations
7.
Lee, Carolyn, Alexander Ungewickell, Aparna Bhaduri, et al.. (2012). Transcriptome sequencing in Sézary syndrome identifies Sézary cell and mycosis fungoides-associated lncRNAs and novel transcripts. Blood. 120(16). 3288–3297. 64 indexed citations
8.
Kawahara, Tiara L.A., Eriko Michishita, Adam S. Adler, et al.. (2009). SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span. Cell. 136(1). 62–74. 900 indexed citations breakdown →
9.
Michishita, Eriko, Adam S. Adler, Elisabeth Berber, et al.. (2009). SIRT6LinksHistoneH3Lysine9Deacetylation to NF-kB-Dependent Gene Expression and Organismal Life Span. 3 indexed citations
10.
Adler, Adam S., Laurie E. Littlepage, Meihong Lin, et al.. (2008). CSN5 Isopeptidase Activity Links COP9 Signalosome Activation to Breast Cancer Progression. Cancer Research. 68(2). 506–515. 56 indexed citations
11.
Wong, David J., Dimitry S.A. Nuyten, Aviv Regev, et al.. (2008). Revealing Targeted Therapy for Human Cancer by Gene Module Maps. Cancer Research. 68(2). 369–378. 45 indexed citations
12.
Adler, Adam S., Meihong Lin, Hugo M. Horlings, et al.. (2006). Genetic regulators of large-scale transcriptional signatures in cancer. Nature Genetics. 38(4). 421–430. 177 indexed citations
13.
Li, Cong, Fang Zhang, Meihong Lin, & Jingwen Liu. (2004). Induction of S100A9 Gene Expression by Cytokine Oncostatin M in Breast Cancer Cells Through the STAT3 Signaling Cascade. Breast Cancer Research and Treatment. 87(2). 123–134. 34 indexed citations
14.
Kong, Weijia, Jing Wei, Parveen Abidi, et al.. (2004). Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine. 10(12). 1344–1351. 1171 indexed citations breakdown →
15.
Li, Cong, Meihong Lin, & Jingwen Liu. (2004). Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis. Oncogene. 23(58). 9336–9347. 45 indexed citations
16.
Zhang, Fang, Meihong Lin, Parveen Abidi, Gerald Thiel, & Jingwen Liu. (2003). Specific Interaction of Egr1 and c/EBPβ Leads to the Transcriptional Activation of the Human Low Density Lipoprotein Receptor Gene. Journal of Biological Chemistry. 278(45). 44246–44254. 59 indexed citations
17.
Liu, Jingwen, et al.. (2003). Synergistic Activation of Human LDL Receptor Expression by SCAP Ligand and Cytokine Oncostatin M. Arteriosclerosis Thrombosis and Vascular Biology. 23(1). 90–96. 19 indexed citations
18.
Nathan, Cherie‐Ann O., Igor L. Leskov, Meihong Lin, et al.. (2001). COX-2 expression in dysplasia of the head and neck. Cancer. 92(7). 1888–1895. 48 indexed citations
19.
Ito, Hiroshi, Susumu Adachi, Mimi Tamamori, et al.. (1996). Mild Hypoxia Induces Hypertrophy of Cultured Neonatal Rat Cardiomyocytes: A Possible Endogenous Endothelin-1-mediated Mechanism. Journal of Molecular and Cellular Cardiology. 28(6). 1271–1277. 57 indexed citations
20.
Ito, Hiroshi, Masato Tanaka, Susumu Adachi, et al.. (1996). Heparin and Heparan Sulfate Block Angiotensin IIInduced Hypertrophy in Cultured Neonatal Rat Cardiomyocytes. Circulation. 93(4). 810–816. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026